Europe Multiplex Assays Market is at the cusp of crossing USD 0.95 billion in 2021
According to the Europe Multiplex
Assays Market Research Report, the market is anticipated to grow at a
7.32% CAGR from 2016 to 2021 and it is estimated that the Europe market was
valued at USD 0.67 billion in 2016 and is expected to reach USD 0.95 billion by
2021.
Browse market data tables and
in-depth TOC of the Europe Multiplex Assays Market to 2021 @ http://www.marketdataforecast.com/market-reports/europe-multiplex-assays-market-4999/
While multiplex bead array assays (MBAA) are
widely ascribed to be a recent innovation, descriptions of these assays can be
found in the literature as far back as 1977. A wide assortment of tests has
been devised for MBAA using both immunological and molecular ligands. The
potential advantages of these assays are apparent, such as the ability to
independently and quantitatively assay multiple analytes simultaneously in
small volumes of material and the collection of data from numerous beads for
each ligand to provide statistical rigor. The potential cost- and time-savings
that could be accrued by use of MBAA in comparison to other methods provides a
strong impetus for the routine use of these in both the research and clinical
laboratories. As with all clinical laboratory tests, questions of
reproducibility, precision, and accuracy must be addressed in order to validate
these assays. This commonly involves a comparison to methods considered to be
the current standards.
Factors such as increasing number of research
& development for treatment of diseases, rising adoption of multiplex
assays to reduce operation costs, technological advancements, and growth in
adoption of personalized medicine for increasing safety & efficacy of therapies
are expected to create new opportunities for the main players during the
analysis period. However, lack of experienced healthcare professionals and huge
capital investments are the major restrains for the market growth.
Inquire before
buying @ http://www.marketdataforecast.com/market-reports/europe-multiplex-assays-market-4999/inquire
This is can be attributed to the increase in
the geriatric population, rise in the prevalence of cataract, and rise in the
government initiatives to eliminate avoidable blindness. Moreover, rise in
adoption of premium lens due to their enhanced visual performance ensures
reduced rates of astigmatism, thus boosting the growth of the market. However,
unfavorable reimbursement schemes and postoperative complications such as
refractive errors are anticipated to have a negative impact on the market
growth.
Free sample of the report is
available @ http://www.marketdataforecast.com/market-reports/europe-multiplex-assays-market-4999/request-sample
Europe Multiplex Assays Market Segmentation
into Product, Technology, Type, Application and End User. On the basis of
product, it is segmented into Consumable, Kits & Reagents and Panels. The
consumables sub-segment is projected to account for the largest share of the
products segment due to increase in the demand of consumables. On the basis of
Technology, it is segmented into PCR and Multiplex Array. The multiplex array
is further segmented into planar arrays and bead-based arrays. The multiplex
arrays segment is projected to hold the largest share of the multiplex assays
market. On the basis of Type, it is segmented into Nucleic Acid-Based and
Protein-Based. Nucleic acid-based assays segment is further classified into
planar nucleic acid assays and bead-based nucleic acid assays. Protein-based
assays segment is further categorized into planar protein assays and bead-based
protein assays. The protein based assays segment is expected to witness the
fastest growing segment of the multiplex assays market. On the basis of
Application, it is segmented into R&D and Companion Diagnostics. The
research & development segment is estimated to account for the largest
share of the multiplex assays market. On the basis of End User, it is segmented
into Hospital and Clinical Laboratory. The pharmaceutical and biotechnology
companies segment is expected to account for the largest share due to
increasing adoption of multiplex assays in this segment.
Multiplex Assays Market Geography, the market
is analyzed under various regions namely Germany, Spain, France, U.K. and
Italy. Europe accounts for the second largest share of the market. This
regional market is driven by the availability of government funds by countries
like Germany, France and U.K.
Avail
discount @ http://www.marketdataforecast.com/market-reports/europe-multiplex-assays-market-4999/request-discount
Europe Multiplex Assays Industry key players
are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad
Laboratories Inc., QIAGEN N.V., Abcam Plc, Becton, Dickinson and Company,
Luminex Corporation, Meso Scale Diagnostics, Randox Laboratories Ltd and
Seegene Inc.
About Us:
Market Data Forecast is a firm working in the
area of market research and business intelligence. With rich experience in
research across various business domains, we cater to the needs of both
individual and corporate clients. Our analyst team comprises expert
professionals in market research, who with their collective knowledge and
skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International
Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Comments
Post a Comment